Scandidos
1.795 SEK +12.89%Be the first to follow this company
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Revenue
61.5M
EBIT %
-13.38 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SDOS
Daily low / high price
1.545 / 1.795
SEK
Market cap
102.33M SEK
Turnover
30.84K SEK
Volume
19K
Financial calendar
Annual report
2024-06-18
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Spore Invest AB | 27.4 % | 27.4 % |
Commerzbank AG, W8IMY - IBA Dosimetry | 10.1 % | 10.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
ScandiDos AB - Delårsrapport 1 maj 2023 – 31 jan 2024
ScandiDos receives orders worth €478 000 from China
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools